Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Regen Biopharma ( (RGBP) ) has issued an update.
On January 15 and January 29, 2026, Regen Biopharma issued a total of 10,302,732 common shares to retire an aggregate of $23,449 in principal and $9,101 in accrued interest on convertible indebtedness, with the shares placed directly by management under a private offering exemption and without the use of underwriters, commissions, or general solicitation. On January 30, 2026, the company raised $50,000 through the direct sale of 11,111,111 common shares under a Tier 2 Regulation A offering, bringing its total common shares outstanding to 129,468,577 as of February 2, 2026, actions that reduced debt while modestly strengthening liquidity but further diluted existing shareholders.
More about Regen Biopharma
Average Trading Volume: 1,011,355
Technical Sentiment Signal: Strong Sell
Current Market Cap: $617K
See more data about RGBP stock on TipRanks’ Stock Analysis page.